Resveratrol attenuates staphylococcal enterotoxin B-activated immune cell metabolism via upregulation of miR-100 and suppression of mTOR signaling pathway

Acute Respiratory Distress Syndrome (ARDS) is triggered by a variety of insults, such as bacterial and viral infections, including SARS-CoV-2, leading to high mortality. In the murine model of ARDS induced by Staphylococcal enterotoxin-B (SEB), our previous studies showed that while SEB triggered 10...

Full description

Saved in:
Bibliographic Details
Main Authors: Hasan Alghetaa (Author), Amira Mohammed (Author), Narendra Singh (Author), Kiesha Wilson (Author), Goushuai Cai (Author), Nagireddy Putluri (Author), Mitzi Nagarkatti (Author), Prakash Nagarkatti (Author)
Format: Book
Published: Frontiers Media S.A., 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_bc02f574a3a14b878a30c0c4586d91d8
042 |a dc 
100 1 0 |a Hasan Alghetaa  |e author 
700 1 0 |a Amira Mohammed  |e author 
700 1 0 |a Narendra Singh  |e author 
700 1 0 |a Kiesha Wilson  |e author 
700 1 0 |a Goushuai Cai  |e author 
700 1 0 |a Nagireddy Putluri  |e author 
700 1 0 |a Mitzi Nagarkatti  |e author 
700 1 0 |a Prakash Nagarkatti  |e author 
245 0 0 |a Resveratrol attenuates staphylococcal enterotoxin B-activated immune cell metabolism via upregulation of miR-100 and suppression of mTOR signaling pathway 
260 |b Frontiers Media S.A.,   |c 2023-02-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2023.1106733 
520 |a Acute Respiratory Distress Syndrome (ARDS) is triggered by a variety of insults, such as bacterial and viral infections, including SARS-CoV-2, leading to high mortality. In the murine model of ARDS induced by Staphylococcal enterotoxin-B (SEB), our previous studies showed that while SEB triggered 100% mortality, treatment with Resveratrol (RES) completely prevented such mortality by attenuating inflammation in the lungs. In the current study, we investigated the metabolic profile of SEB-activated immune cells in the lungs following treatment with RES. RES-treated mice had higher expression of miR-100 in the lung mononuclear cells (MNCs), which targeted mTOR, leading to its decreased expression. Also, Single-cell RNA-seq (scRNA seq) unveiled the decreased expression of mTOR in a variety of immune cells in the lungs. There was also an increase in glycolytic and mitochondrial respiration in the cells from SEB + VEH group in comparison with SEB + RES group. Together these data suggested that RES alters the metabolic reprogramming of SEB-activated immune cells, through suppression of mTOR activation and its down- and upstream effects on energy metabolism. Also, miR-100 could serve as novel potential therapeutic molecule in the amelioration of ARDS. 
546 |a EN 
690 |a MiR-100 
690 |a ARDS (acute respiratory disease syndrome) 
690 |a T-cell metabolism 
690 |a mTOR 
690 |a staphylococcal enterotoxin B (SEB) 
690 |a resveratrol 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 14 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2023.1106733/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/bc02f574a3a14b878a30c0c4586d91d8  |z Connect to this object online.